| H02AB06 |
Prednisolone |
Prednisolon Cortico |
Tablet |
5 |
mg |
20 |
Антибиотик Разград АД, България |
10 |
mg |
- |
3.07 |
0.307 |
3.07 |
50% |
1.54 |
|
D69.3,E06.1,E27.1,G35,H16.0,H16.1,H16.2,H16.3,H20.0,J45.0,J45.1,K50.0,K50.1,K51.2,L10.0,L10.1,L10.2,L10.3,L10.4,L10.5,L10.8,M05.0,M05.1,M05.2,M05.3,M05.8,M07.1,M07.2,M07.3,M08.1,M08.2,M08.3,M08.4,M30.0,M32.1,M32.8,M33.0,M33.1,M33.2,M34.0,M34.1,M34.2,M34.8,M45.0 |
№ 70/ 19.04.2010; № 99/ 23.08.2010; № 210/ 04.11.2011; КЦРР-2370/21.02.2013 г.; НСР-8529/16.03.2016; НСР-9081/21.04.2016; НСР-13239/17.07.2017 |
02.09.2017 |
08.09.2012 |
|
Заличен |
1682 |
| H02AB07 |
Prednisone |
H02AB07 Prednisone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| H02AB07 |
Prednisone |
Dehydrocortison |
Film coated tablet |
5 |
mg |
60 |
Антибиотик Разград АД, България |
10 |
mg |
- |
5.58 |
0.186 |
5.58 |
50% |
2.79 |
|
D69.3,E06.1,E27.1,G35,G70.0,J45.0,J45.1,K50.0,K50.1,K51.2,L10.0,L10.1,L10.2,L10.3,L10.4,L10.5,L10.8,M05.0,M05.1,M05.2,M05.3,M05.8,M07.1,M07.2,M07.3,M08.1,M08.2,M08.3,M08.4,M30.0,M31.3,M32.1,M32.8,M33.0,M33.1,M33.2,M34.0,M34.1,M34.2,M34.8,M45.0 |
№ 92/23.06.2010; КЦРР-1173/08.08.2012 г.; протокол № 46/12.12.2013; НСР-12603/05.05.2017 |
02.06.2017 |
08.09.2012 |
|
Заличен |
1319 |
| H02BX01 |
Methylprednisolone, Lidocaine |
H02BX01 Methylprednisolone, Lidocaine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| H02BX01 |
Methylprednisolone, Lidocaine |
Depo-Medrol with Lidocaine 40 mg/10 mg/ml - 1ml |
Suspension for injection |
50 |
mg/ml |
1 |
Pfizer Enterprises SARL, Люксембург |
50 |
mg |
- |
1.73 |
1.73 |
1.73 |
50% |
0.87 |
|
M05.0,M05.1,M05.2,M05.3,M05.8,M08.1,M08.2,M08.3,M08.4,M32.1,M32.8,M33.0,M33.1,M33.2,M34.1,M34.2 |
№25/03.08.2009; НСР-4364/05.08.2014 |
02.09.2014 |
08.09.2012 |
|
Заличен |
602 |
| H02BX01 |
Methylprednisolone, Lidocaine |
Depo-Medrol with Lidocaine 40 mg/10 mg/ml - 2 ml |
Suspension for injection |
100 |
mg/2ml |
1 |
Pfizer Enterprises SARL, Люксембург |
50 |
mg |
- |
8.78 |
1.73 |
3.46 |
50% |
1.73 |
|
M05.0,M05.1,M05.2,M05.3,M05.8,M08.1,M08.2,M08.3,M08.4,M32.1,M32.8,M33.0,M33.1,M33.2,M34.1,M34.2 |
НСР-4365/05.08.2014 |
02.09.2014 |
08.09.2012 |
|
Заличен |
603 |
| H03AA01 |
Levothyroxine |
H03AA01 Levothyroxine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| H03AA01 |
Levothyroxine sodium |
Euthyrox |
Tablet |
0.025 |
mg |
30 |
Merck KGaA, Германия |
0.15 |
mg |
0.95 |
- |
0.0717 |
0.36 |
100% |
0.36 |
|
E03.0,E03.1,E03.2,E03.3,E03.4,E03.8,E04.0,E05.0,E05.1,E05.2,E05.3,E06.1,E06.2,E06.3,E06.4,E06.5 |
НСР-1996/06.12.2013; НСР-9136/27.04.2016 |
02.06.2016 |
|
|
Заличен |
2347 |
| H03AA01 |
Levothyroxine sodium |
Euthyrox |
Tablet |
0.125 |
mg |
30 |
Merck KGaA, Германия |
0.15 |
mg |
4.6 |
- |
0.0717 |
1.79 |
100% |
1.79 |
|
E03.0,E03.1,E03.2,E03.3,E03.4,E03.8,E04.0,E05.0,E05.1,E05.2,E05.3,E06.1,E06.2,E06.3,E06.4,E06.5 |
НСР-1996/06.12.2013; НСР-9137/27.04.2016 |
02.06.2016 |
|
|
Заличен |
2351 |
| H03AA01 |
Levothyroxine sodium |
Euthyrox |
Tablet |
0.1 |
mg |
30 |
Merck KGaA, Германия |
0.15 |
mg |
3.7 |
- |
0.0717 |
1.43 |
100% |
1.43 |
|
E03.0,E03.1,E03.2,E03.3,E03.4,E03.8,E04.0,E05.0,E05.1,E05.2,E05.3,E06.1,E06.2,E06.3,E06.4,E06.5 |
НСР-1996/06.12.2013; НСР-9138/27.04.2016 |
02.06.2016 |
|
|
Заличен |
2349 |
| H03AA01 |
Levothyroxine sodium |
Euthyrox |
Tablet |
0.075 |
mg |
30 |
Merck KGaA, Германия |
0.15 |
mg |
2.78 |
- |
0.0717 |
1.08 |
100% |
1.08 |
|
E03.0,E03.1,E03.2,E03.3,E03.4,E03.8,E04.0,E05.0,E05.1,E05.2,E05.3,E06.1,E06.2,E06.3,E06.4,E06.5 |
НСР-1996/06.12.2013; НСР-9139/27.04.2016 |
02.06.2016 |
|
|
Заличен |
2350 |
| H03AA01 |
Levothyroxine sodium |
Euthyrox |
Tablet |
0.05 |
mg |
30 |
Merck KGaA, Германия |
0.15 |
mg |
1.84 |
- |
0.0717 |
0.72 |
100% |
0.72 |
|
E03.0,E03.1,E03.2,E03.3,E03.4,E03.8,E04.0,E05.0,E05.1,E05.2,E05.3,E06.1,E06.2,E06.3,E06.4,E06.5 |
НСР-1996/06.12.2013; НСР-9140/27.04.2016 |
02.06.2016 |
|
|
Заличен |
2348 |
| H03AA01 |
Levothyroxine sodium |
EUTHYROX |
Tablet |
0.125 |
mg |
100 |
Merck KGaA, Германия |
0.15 |
mg |
5.98 |
- |
0.0669 |
5.58 |
100% |
5.58 |
|
E03.0,E03.1,E03.2,E03.3,E03.4,E03.8,E04.0,E05.0,E05.1,E05.2,E05.3,E06.1,E06.2,E06.3,E06.4,E06.5 |
КЦРР-225/27.02.2012 г.; НСР-4001/30.06.2014 |
02.08.2014 |
08.09.2012 |
|
Заличен |
1141 |
| H03AA01 |
Levothyroxine sodium |
EUTHYROX |
Tablet |
0.1 |
mg |
100 |
Merck KGaA, Германия |
0.15 |
mg |
4.46 |
- |
0.0669 |
4.46 |
100% |
4.46 |
|
E03.0,E03.1,E03.2,E03.3,E03.4,E03.8,E04.0,E05.0,E05.1,E05.2,E05.3,E06.1,E06.2,E06.3,E06.4,E06.5 |
НСР-4001/30.06.2014 |
02.08.2014 |
08.09.2012 |
|
Заличен |
630 |
| H03AA01 |
Levothyroxine sodium |
EUTHYROX |
Tablet |
0.075 |
mg |
100 |
Merck KGaA, Германия |
0.15 |
mg |
4.7 |
- |
0.0669 |
3.35 |
100% |
3.35 |
|
E03.0,E03.1,E03.2,E03.3,E03.4,E03.8,E04.0,E05.0,E05.1,E05.2,E05.3,E06.1,E06.2,E06.3,E06.4,E06.5 |
КЦРР-225/27.02.2012 г.; НСР-4001/30.06.2014 |
02.08.2014 |
08.09.2012 |
|
Заличен |
1140 |
| H03AA01 |
Levothyroxine sodium |
EUTHYROX |
Tablet |
0.05 |
mg |
100 |
Merck KGaA, Германия |
0.15 |
mg |
3.16 |
- |
0.0669 |
2.23 |
100% |
2.23 |
|
E03.0,E03.1,E03.2,E03.3,E03.4,E03.8,E04.0,E05.0,E05.1,E05.2,E05.3,E06.1,E06.2,E06.3,E06.4,E06.5 |
НСР-4001/30.06.2014 |
02.08.2014 |
08.09.2012 |
|
Заличен |
629 |
| H03AA01 |
Levothyroxine sodium |
EUTHYROX |
Tablet |
0.025 |
mg |
100 |
Merck KGaA, Германия |
0.15 |
mg |
3.65 |
- |
0.0669 |
1.12 |
100% |
1.12 |
|
E03.0,E03.1,E03.2,E03.3,E03.4,E03.8,E04.0,E05.0,E05.1,E05.2,E05.3,E06.1,E06.2,E06.3,E06.4,E06.5 |
КЦРР-225/27.02.2012 г.; НСР-3715/06.06.2014; НСР-3922/20.06.2014 |
16.07.2014 |
08.09.2012 |
|
Заличен |
1139 |
| H03AA01 |
Levothyroxine sodium |
L-Thyroxin 100 Berlin-Chemie |
Tablet |
100 |
mcg |
100 |
Berlin-Chemie AG (Menarini Group), Германия |
0.15 |
mg |
4.78 |
- |
0.0717 |
4.78 |
100% |
4.78 |
|
E03.0,E03.1,E03.2,E03.3,E03.4,E03.8,E04.0,E05.0,E05.1,E05.2,E05.3,E06.1,E06.2,E06.3,E06.4,E06.5 |
|
02.08.2014 |
08.09.2012 |
|
Активен |
32 |
| H03AA01 |
Levothyroxine sodium |
L-Thyroxin 150 Berlin-Chemie |
Tablet |
150 |
mcg |
50 |
Berlin-Chemie AG (Menarini Group), Германия |
0.15 |
mg |
3.79 |
- |
0.0717 |
3.59 |
100% |
3.59 |
|
E03.0,E03.1,E03.2,E03.3,E03.4,E03.8,E04.0,E05.0,E05.1,E05.2,E05.3,E06.1,E06.2,E06.3,E06.4,E06.5 |
НСР-6758/23.07.2015.; НСР-10451/29.09.2016; НСР-18892/06.06.2019 |
02.07.2019 |
|
|
Активен |
4050 |
| H03AA01 |
Levothyroxine sodium |
L-Thyroxin 50 Berlin-Chemie |
Tablet |
50 |
mcg |
50 |
Berlin-Chemie AG (Menarini Group), Германия |
0.15 |
mg |
2.83 |
- |
0.0717 |
1.2 |
100% |
1.2 |
|
E03.0,E03.1,E03.2,E03.3,E03.4,E03.8,E04.0,E05.0,E05.1,E05.2,E05.3,E06.1,E06.2,E06.3,E06.4,E06.5 |
КЦРР-2750/20.03.2013 г.; НСР-9492/09.06.2016 |
02.07.2016 |
08.09.2012 |
|
Активен |
1821 |
| H03AA01 |
Levothyroxine sodium |
L-Thyroxin 75 Berlin-Chemie |
Tablet |
75 |
mcg |
50 |
Berlin-Chemie AG (Menarini Group), Германия |
0.15 |
mg |
2.16 |
- |
0.0717 |
1.79 |
100% |
1.79 |
|
E03.0,E03.1,E03.2,E03.3,E03.4,E03.8,E04.0,E05.0,E05.1,E05.2,E05.3,E06.1,E06.2,E06.3,E06.4,E06.5 |
НСР-6392/03.06.2015.; НСР-10012/18.08.2016 |
02.10.2016 |
|
|
Активен |
4055 |
| H03BA02 |
Propylthiouracil |
H03BA02 Propylthiouracil |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| H03BA02 |
Propylthiouracil |
Propycil |
Tablet |
50 |
mg |
100 |
Admeda Arzneimittel GmbH, Германия |
100 |
mg |
- |
20.47 |
0.4094 |
20.47 |
50% |
10.23 |
|
E05.0,E05.1,E05.2,E05.3 |
№ 16/24.06.2009 г.; КЦРР-700/05.06.2012 г.; НСР-4657/ 25.09.2014.; НСР-6320/28.05.2015.; НСР-12525/28.04.2017; НСР-12859/26.05.2017 допуска предварително изпълнение; КП-17/28.01.2019 и НСР-16242/27.07.2018 |
02.04.2019 |
08.09.2012 |
|
Активен |
3251 |
| H03BB02 |
Thiamazole |
H03BB02 Thiamazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| H03BB02 |
Thiamazole |
Metizol |
Tablet |
5 |
mg |
50 |
Майлан ЕООД, България |
10 |
mg |
- |
2.92 |
0.1168 |
2.92 |
50% |
1.46 |
|
E05.0,E05.1,E05.2,E05.3 |
НСР-6068/16.04.2015.; НСР-17947/18.02.2019 |
02.04.2019 |
|
|
Активен |
3840 |